According to the timeROC curve analysis (Figure 3G), ARNTL significantly predicted the survival of AML (1-, 2-, and 3-year AUC of 0.533, 0.619, and 0.622, respectively). The gene discussed is BMAL1; the disease is acute myeloid leukemia.